Last reviewed · How we verify
Sevoflurane intravenous anesthesia — Competitive Intelligence Brief
phase 3
Volatile anesthetic
GABA_A receptor
Anesthesiology
Small molecule
Live · refreshed every 30 min
Target snapshot
Sevoflurane intravenous anesthesia (Sevoflurane intravenous anesthesia) — The Cleveland Clinic. Sevoflurane acts as a general anesthetic by modulating the activity of the GABA_A receptor, leading to a decrease in neuronal excitability.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Sevoflurane intravenous anesthesia TARGET | Sevoflurane intravenous anesthesia | The Cleveland Clinic | phase 3 | Volatile anesthetic | GABA_A receptor | |
| The midazolam ketamine group | The midazolam ketamine group | Kasr El Aini Hospital | phase 3 | Benzodiazepine and NMDA receptor antagonist | GABA_A receptor, NMDA receptor | |
| Remifentanil and/or propofol | Remifentanil and/or propofol | Alder Hey Children's NHS Foundation Trust | phase 3 | Opioid analgesic, Sedative-hypnotic | Opioid receptors, GABA_A receptor | |
| Propofol-Lipuro | Propofol-Lipuro | University Hospital, Grenoble | phase 3 | GABA receptor agonist | GABA_A receptor | |
| propofol (drug) | propofol (drug) | B. Braun Melsungen AG | phase 3 | GABA receptor agonist | GABA_A receptor | |
| Stiripentol Oral Capsule | Stiripentol Oral Capsule | Biocodex | phase 3 | GABA_A receptor modulator | GABA_A receptor | |
| topiramate, propranolol | topiramate, propranolol | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | phase 3 | Anticonvulsant | Voltage-dependent sodium channels, GABA_A receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Volatile anesthetic class)
- Medical University of Gdansk · 2 drugs in this class
- Assistance Publique - Hôpitaux de Paris · 1 drug in this class
- Federal University of São Paulo · 1 drug in this class
- King's College Hospital NHS Trust · 1 drug in this class
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · 1 drug in this class
- The Cleveland Clinic · 1 drug in this class
- University Hospital, Basel, Switzerland · 1 drug in this class
- Asan Medical Center · 1 drug in this class
- University Hospital, Clermont-Ferrand · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Sevoflurane intravenous anesthesia CI watch — RSS
- Sevoflurane intravenous anesthesia CI watch — Atom
- Sevoflurane intravenous anesthesia CI watch — JSON
- Sevoflurane intravenous anesthesia alone — RSS
- Whole Volatile anesthetic class — RSS
Cite this brief
Drug Landscape (2026). Sevoflurane intravenous anesthesia — Competitive Intelligence Brief. https://druglandscape.com/ci/sevoflurane-intravenous-anesthesia. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab